Company / Operating Income per Share
AIM ImmunoTech Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$17.80
FY2025
5-year range
-$17.80 / -$0.36
FY2021-FY2025
Trend
-2638.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed -2639% YoY in FY2025, a notable deviation from the 9-year average annual change of -624%.
Based on SEC 10-K filings.
-17.80 in FY2025.
Declined from $-0.41 to $-17.80 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- AIM ImmunoTech Inc.'s operating income per share has declined for 4 consecutive years.
- In FY2025, operating income per share decreased 2638.6% year-over-year.
- Peak operating income per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -71.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$17.80 | -2638.6% |
| FY2024 | -$0.65 | -56.9% |
| FY2023 | -$0.41 | -5.6% |
| FY2022 | -$0.39 | -9.2% |
| FY2021 | -$0.36 | +75.4% |
| FY2020 | -$1.46 | +87.0% |
| FY2019 | -$11.23 | -3113.6% |
| FY2018 | -$0.35 | +49.2% |
| FY2017 | -$0.69 | -2.8% |
| FY2016 | -$0.67 | -719.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026